UNH vs DGX
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Quest Diagnostics Incorporated, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | DGX |
|---|---|---|
| Price | $407.46 | $259.60 |
| Market cap | $365.09B | $28.56B |
| P/E ratio | 23.3 | 25.9 |
| ROE | 15.77% | 15.32% |
| Profit margin | 3.53% | 9.54% |
| Revenue growth | -0.40% | 10.00% |
| Dividend yield | 2.28% | 1.33% |
| Beta | 0.52 | 0.55 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs DGX in plain English
- UNH is the bigger company — about 12.8× the market cap of DGX.
- UNH is cheaper on earnings (P/E 23.3 vs 25.9).
- UNH earns a higher return on equity (16% vs 15%).
- DGX is growing revenue faster (10% vs -0%).
- UNH has the higher dividend yield (2.28% vs 1.33%).
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
DGX return calculator
See what $1,000 in Quest Diagnostics Incorporated would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.